CPhI Online

- Market News

ProductLife Group acquires pharmacovigilance services provider

13 Oct 2020

The strategic acquisition of Axpharma is part of the group’s aim to widen its expertise and global reach as the pandemic forces renewed focus on safety, quality and speed-to-market.

ProductLife Group (PLG), a specialist provider of regulatory and compliance services for the life sciences industry, is to acquire pharmacovigilance services provider, Axpharma, in response to a growing focus on safety, quality and speed-to-market during the continuing pandemic.

According to PLG, pharmacovigilance (PV) services, in particular, are facing strong and growing international demand from life sciences companies and PLG’s PV capabilities will be strongly bolstered via the Axpharma deal.

Founded in 2001, Axpharma is a prominent pharmacovigilance service provider in Europe. Its team of experts provides services in pharmacovigilance responsibility, case management, literature research, medical writing and around-the-clock medical information. Its clients include pharmaceutical, biopharmaceutical medical device and cosmetics companies.

Commenting on the Axpharma acquisition, PLG CEO Xavier Duburcq said: “The merger of PLG and Axpharma offers tremendous potential to further invest in automation and artificial intelligence, as part of our aim to offer reliable, innovative, and cost-effective solutions to our clients that are always one step ahead of what the industry expects.”

Related Content